A phase 1 study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma

Angela Dispenzieri, G. A. Wiseman, M. Q. Lacy, M. R. Litzow, P. M. Anderson, D. A. Gastineau, A. Tefferi, D. J. Inwards, I. N.M. Micallef, S. M. Ansell, L. Porrata, M. A. Elliot, J. A. Lust, P. R. Greipp, S. V. Rajkumar, R. Fonseca, T. E. Witzig, C. Erlichman, J. A. Sloan, M. A. Gertz

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myeloma'. Together they form a unique fingerprint.

Medicine & Life Sciences